Gene: SLC25A30
Official Full Name: solute carrier family 25 member 30provided by HGNC
Gene Summary: Although the outer mitochondrial membrane is permeable to many small metabolites, transport of solutes across the inner mitochondrial membrane is achieved by members of the mitochondrial carrier protein family, such as SLC25A30 (Haguenauer et al., 2005 [PubMed 15809292]).[supplied by OMIM, Mar 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO21235 | SLC25A30 Knockout cell line (HeLa) | Human | SLC25A30 | 1:3~1:6 | Negative | Online Inquiry |
KO21236 | SLC25A30 Knockout cell line (HCT 116) | Human | SLC25A30 | 1:2~1:4 | Negative | Online Inquiry |
KO21237 | SLC25A30 Knockout cell line (HEK293) | Human | SLC25A30 | 1:3~1:6 | Negative | Online Inquiry |
KO21238 | SLC25A30 Knockout cell line (A549) | Human | SLC25A30 | 1:3~1:4 | Negative | Online Inquiry |
SLC25A30 Gene Knockout Cell Lines are genetically engineered cell lines specifically designed to lack the expression of the SLC25A30 gene, which encodes for the mitochondrial dicarboxylate carrier. This manipulation facilitates the study of mitochondrial dynamics and metabolic pathways, allowing researchers to investigate the implications of dicarboxylate transport on cellular functions, energy metabolism, and mitochondrial health.
The key mechanism of these cell lines involves the complete abrogation of SLC25A30 activity, leading to alterations in mitochondrial transport processes, specifically the exchange of metabolites such as malate and succinate across the inner mitochondrial membrane. This knockout provides a unique platform to explore the resulting biochemical and phenotypic changes, such as variations in mitochondrial respiration, reactive oxygen species production, and overall cell viability under various stress conditions.
In research settings, SLC25A30 Gene Knockout Cell Lines serve as invaluable tools for elucidating the roles of mitochondrial transporters in physiological and pathological contexts, including cancer, metabolic disorders, and age-related diseases. The ability to analyze how the loss of SLC25A30 impacts energy metabolism enhances our understanding of mitochondrial function and disease mechanisms at a molecular level.
In comparison to traditional cell lines, the specificity of these knockout models allows for a more refined analysis of gene function. By focusing on the targeted disruption of the SLC25A30 gene, researchers can draw clearer conclusions regarding the gene’s roles and interactions in cellular processes, ultimately leading to enhanced experimental accuracy.
For clinicians and researchers alike, these cell lines provide a significant advantage by streamlining experimental designs and improving reproducibility, which is crucial for advancing scientific knowledge and therapeutic development.
Our company specializes in the development of cutting-edge genetic tools for cellular and molecular biology, backed by a commitment to quality and innovation. We are dedicated to empowering researchers with reliable resources that contribute to groundbreaking discoveries in the life sciences.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.